SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-017222
Filing Date
2022-08-15
Accepted
2022-08-15 07:17:19
Documents
64
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pyxs-20220630.htm   iXBRL 10-Q 2597732
2 EX-31.1 pyxs-ex31_1.htm EX-31.1 18772
3 EX-31.2 pyxs-ex31_2.htm EX-31.2 18765
4 EX-32.1 pyxs-ex32_1.htm EX-32.1 12310
5 EX-32.2 pyxs-ex32_2.htm EX-32.2 11643
6 GRAPHIC img30575050_0.jpg GRAPHIC 71662
  Complete submission text file 0000950170-22-017222.txt   7531900

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pyxs-20220630_lab.xml EX-101.LAB 368452
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pyxs-20220630.xsd EX-101.SCH 40029
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pyxs-20220630_pre.xml EX-101.PRE 276388
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pyxs-20220630_cal.xml EX-101.CAL 30671
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pyxs-20220630_def.xml EX-101.DEF 153877
58 EXTRACTED XBRL INSTANCE DOCUMENT pyxs-20220630_htm.xml XML 1074969
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

IRS No.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40881 | Film No.: 221162304
SIC: 2834 Pharmaceutical Preparations